Boeing shares are rising as investors react to fresh signs of regulatory progress on the long-delayed 777X, after the FAA cleared the aircraft for the next phase of certification testing in March 2026. The development reduces near-term uncertainty around the program’s path to approval and helps reinforce the broader turnaround narrative tied to higher deliveries and improving cash generation.

The 777X has been a focal point for sentiment because certification delays have repeatedly pushed out the schedule and raised concerns about costs, customer patience, and long-term widebody competitiveness. Moving into the next FAA testing phase is viewed as a tangible step toward de-risking the program, which could eventually translate into deliveries, customer payments, and better absorption of fixed costs.

Traders are likely to focus on whether Boeing can keep the certification program on track and avoid new quality or supply-chain setbacks that could slow testing and production. Near-term catalysts include any additional FAA approvals, clearer delivery timing updates for the 777X, and confirmation that 2026 delivery increases across key programs can convert backlog into cash flow.